Breakthrough Alzheimer’s drugs too pricey for NHS

Two breakthrough Alzheimer’s drugs cost too much and have too little benefit for NHS use, review finds.

About the Author

has written 41538 stories on this site.

Copyright © 2010 Business and Corporate News.